YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)


AddThis Social Bookmark Button

Injured by Avonex?

On February 28, 2005, the FDA reported people suffering PML (Progressive Multifocal Leukoencephalopathy) while taking Avonex. In many circumstances those who suffer from Multiple Sclerosis take both Avonex and Tysabri together. Tysabri was withdrawn from the market after recent reports of two cases of serious effects among patients who used it along with an earlier Avonex, in clinical trials. In one instance, the person died, while in another, the person developed a suspected case of Progressive Multifocal Leukoencephalopathy, a rare and frequently fatal disease of the central nervous system.

PML (Progressive Multifocal Leukoencephalopathy) often results in irreversible neurological deterioration and death. Both patients had taken Avonex for more than two years in combination with Tysabri, the companies said. Symptoms of PML (Progressive Multifocal Leukoencephalopathy) include mental deterioration, vision loss, speech disturbances, ataxia (inability to coordinate movements), paralysis, and, ultimately, coma reflecting the multifocal distribution of brain lesions. In rare cases, seizures may occur.

On March 16, 2005, the FDA warned that Avonex might cause severe liver damage. Avonex, manufactured by Biogen, Inc. was approved on May 17, 1996 to combat Multiple Sclerosis.

Biogen spokeswoman Amy Ryan said the change was “a minor update” to the Avonex label. She said the company had received “very, very few” reports of liver damage in Avonex patients, but declined to give specific numbers. “It is a very rare issue,” she said.

In 2004 Avonex, had $1.42 billion in sales.

If you or a loved one took Avonex and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
AvonexRSS Feed

Drug Companies & Continuing Medical Education: It's Not Really About The Teaching

Jun 15, 2007 | Parker Waichman Alonso LLP
A report released last month by the Senate Finance Committee revealed a dirty little secret about pharmaceutical marketing.  Drug companies are bribing doctors to prescribe certain medications.  But pharmaceutical companies are not exactly slipping physicians envelopes stuffed with cash - their approach is far more subtle and effective than that.  Instead, drug manufactures are footing the bill for Continuing Medical Education. In addition to the coursework, these programs often...

More Avonex News

Avonex
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News